{
  "disease_name": "DPM3-CDG",
  "orpha_code": "263494",
  "drugs": [
    {
      "name": "Human laminin-111, recombinant",
      "substance_url": "/en/drug/substance/604968?name=263494&mode=orpha&region=&status=all",
      "substance_id": "604968",
      "regulatory_url": "/en/drug/regulatory/604969?name=263494&mode=orpha&region=",
      "regulatory_id": "604969",
      "orpha_substance_code": "ORPHA:97242",
      "details": [
        "Human laminin-111, recombinant(Medicinal product                        - 06/01/2021)Disease(s) concernedORPHA:97242 Congenital muscular dystrophy",
        "Human laminin-111, recombinant(Medicinal product                        - 06/01/2021)",
        "(Medicinal product                        - 06/01/2021)",
        "Disease(s) concernedORPHA:97242 Congenital muscular dystrophy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604968?name=263494&mode=orpha&region=&status=all",
          "text": "Human laminin-111, recombinant",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/97242",
          "text": "ORPHA:97242 Congenital muscular dystrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604969?name=263494&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=263494&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=263494&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=263494&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=263494&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Insulin-like Growth Factor-1",
      "substance_url": "/en/drug/substance/632336?name=263494&mode=orpha&region=&status=all",
      "substance_id": "632336",
      "regulatory_url": "/en/drug/regulatory/632337?name=263494&mode=orpha&region=",
      "regulatory_id": "632337",
      "orpha_substance_code": "ORPHA:97242",
      "details": [
        "Insulin-like Growth Factor-1(Medicinal product                        - 11/04/2022)Disease(s) concernedORPHA:97242 Congenital muscular dystrophy",
        "Insulin-like Growth Factor-1(Medicinal product                        - 11/04/2022)",
        "(Medicinal product                        - 11/04/2022)",
        "Disease(s) concernedORPHA:97242 Congenital muscular dystrophy",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/632336?name=263494&mode=orpha&region=&status=all",
          "text": "Insulin-like Growth Factor-1",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/97242",
          "text": "ORPHA:97242 Congenital muscular dystrophy",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/632337?name=263494&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=263494&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=263494&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=263494&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=263494&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=263494&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=263494&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=263494&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=263494&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T05:59:33.101345",
  "run_number": 1,
  "total_drugs_found": 5,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=DPM3-CDG&orphaCode=263494&name=263494&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "DPM3-CDG",
    "orphaCode": "263494",
    "name": "263494",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}